Application of Liquid Chromatography Coupled to Mass Spectrometry for Direct Estimation of the Total Levels of Adenosine and Its Catabolites in Human Blood

Jakub Šofranko,Peter Mitro,Zora Lazúrová,Martin Jozef Péč,Tomáš Bolek,Renata Péčová,Matúš Dohál,Matej Samoš,Radovan Murín

DOI: https://doi.org/10.3390/ph17030345

IF: 4.6

2024-03-08

Pharmaceuticals

Abstract:Adenosine is a multifunctional nucleoside with several roles across various levels in organisms. Beyond its intracellular involvement in cellular metabolism, extracellular adenosine potently influences both physiological and pathological processes. In relation to its blood level, adenosine impacts the cardiovascular system, such as heart beat rate and vasodilation. To exploit the adenosine levels in the blood, we employed the liquid chromatography method coupled with mass spectrometry (LC–MS). Immediately after collection, a blood sample mixed with acetonitrile solution that is either enriched with 13C-labeled adenosine or a newly generated mixture is transferred into the tubes containing the defined amount of 13C-labeled adenosine. The 13C-enriched isotopic adenosine is used as an internal standard, allowing for more accurate quantification of adenosine. This novel protocol for LC–MS-based estimation of adenosine delivers a rapid, highly sensitive, and reproducible means for quantitative estimation of total adenosine in blood. The method also allows for quantification of a few catabolites of adenosine, i.e., inosine, hypoxanthine, and xanthine. Our current setup did not allow for the detection or quantifying of uric acid, which is the final product of adenosine catabolism. This advancement provides an analytical tool that has the potential to enhance our understanding of adenosine's systemic impact and pave the way for further investigations into its intricate regulatory mechanisms.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of an efficient, sensitive, and reproducible method to directly estimate the total amount of adenosine and its metabolites (such as inosine, hypoxanthine, and xanthine) in human blood. Specifically, the researchers employed liquid chromatography-mass spectrometry (LC–MS) technology, adding carbon-13 labeled adenosine as an internal standard immediately after blood sample collection to improve the accuracy of adenosine quantification. This method not only allows for the rapid detection of adenosine but also simultaneously detects its major metabolites, thereby aiding in a deeper understanding of the impact of adenosine levels in the blood on the cardiovascular system and other physiological functions. Additionally, this method is highly standardized and can be used to explore the mechanisms of dynamic changes in adenosine concentration in the blood.